Investor's Calendar

September 2022

Mon Tue Wed Thu Fri Sat Sun
29
30
31
1
2
3
4
 
 
 
 
 
 
 
5
6
7
8
9
10
11
 
 
 
 
 
 
 
12
13
14
15
16
17
18
 
 
 
 
 
 
 
19
20
21
22
23
24
25
 
 
 
 
 
 
 
26
27
28
29
30
1
2
 
 
 
 
 
 
 

Next Events

Last News

Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the...
4 min
02 Apr, 2024
This public-private collaboration instrument falls within the framework of the Vanguard Health Strategic...
3 min
12 Mar, 2024
ROVI achieved operating revenue growth of 1% in the first post-pandemic year
4 min
27 Feb, 2024

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email